Literature DB >> 2906199

Calcium accumulation by glutamate receptor activation is involved in hippocampal cell damage after ischemia.

H Benveniste1, M B Jørgensen, N H Diemer, A J Hansen.   

Abstract

Rats exposed to 10 min of complete cerebral ischemia develop necrosis of the CA-1 region of the hippocampus after 2-3 days. We studied the involvement of synaptic transmission for this process by ablation of the afferent input (which is mainly glutamatergic) to CA1 by bilateral destruction of CA-3 neurons (Schafferotomi). The deafferentiation completely prevented the ischemic nerve cell destruction as revealed by histological studies after 6 days. The role of intracellular Ca++ overload was assessed by measurement of the interstitial Ca++ concentration. In control animals the interstitial Ca++ concentration decreases abruptly to 10% of the initial value 1.6 min after the onset of ischemia. The denervated hippocampi, however, showed no decrease during the 10 min of ischemia and hippocampi injected with 2-amino-5-phosphovalerate (APV), a competitive antagonist of the glutamate N-methyl-D-aspartate (NMDA) receptors, displayed a significantly reduced decrease (45% of the initial value) during ischemia. It is concluded that calcium influx via the glutamate-operated channels during the ischemic period is an important link in the development of ischemic brain cell damage.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2906199     DOI: 10.1111/j.1600-0404.1988.tb03697.x

Source DB:  PubMed          Journal:  Acta Neurol Scand        ISSN: 0001-6314            Impact factor:   3.209


  26 in total

1.  Cytosolic Ca2+ changes during in vitro ischemia in rat hippocampal slices: major roles for glutamate and Na+-dependent Ca2+ release from mitochondria.

Authors:  Y Zhang; P Lipton
Journal:  J Neurosci       Date:  1999-05-01       Impact factor: 6.167

Review 2.  Calcium, energy metabolism and the development of selective neuronal loss following short-term cerebral ischemia.

Authors:  N R Sims
Journal:  Metab Brain Dis       Date:  1995-09       Impact factor: 3.584

Review 3.  Taming glutamate excitotoxicity: strategic pathway modulation for neuroprotection.

Authors:  Ming Jia; Steve A Noutong Njapo; Vaibhav Rastogi; Vishnumurthy Shushrutha Hedna
Journal:  CNS Drugs       Date:  2015-02       Impact factor: 5.749

4.  Selective vulnerability in the gerbil hippocampus: morphological changes after 5-min ischemia and long survival times.

Authors:  P Bonnekoh; A Barbier; U Oschlies; K A Hossmann
Journal:  Acta Neuropathol       Date:  1990       Impact factor: 17.088

5.  Characterization of endogenous amino acid efflux from hippocampal slices during chemically-induced ischemia.

Authors:  S Djali; L A Dawson
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

6.  Developmental expression of N-methyl-D-aspartate (NMDA)-induced neurotoxicity, NMDA receptor function, and the NMDAR1 and glutamate-binding protein subunits in cerebellar granule cells in primary cultures.

Authors:  Y Xia; R E Ragan; E E Seah; M L Michaelis; E K Michaelis
Journal:  Neurochem Res       Date:  1995-05       Impact factor: 3.996

7.  Role of extracellular calcium in anoxic injury of mammalian central white matter.

Authors:  P K Stys; B R Ransom; S G Waxman; P K Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-06       Impact factor: 11.205

8.  Long-term changes in gerbil brain neurotransmitter receptors following transient cerebral ischaemia.

Authors:  T Araki; H Kato; K Kogure; Y Kanai
Journal:  Br J Pharmacol       Date:  1992-10       Impact factor: 8.739

9.  Delayed neuronal death and delayed neuronal recovery in the human brain following global ischemia.

Authors:  M Horn; W Schlote
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

10.  Time profile of calcium accumulation in hippocampus, striatum and frontoparietal cortex after transient forebrain ischemia in the gerbil.

Authors:  P Bonnekoh; T Kuroiwa; O Kloiber; K Hossmann
Journal:  Acta Neuropathol       Date:  1992       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.